Thus, we confirmed that the panel of Oct4 and CD26 was able to identify CRC patients, and the panel of c-MYC and CXCR4 was able to identify polyp/CRC patients with a better performance among different gene sets. Here, CXCR4 is linked to colorectal carcinoma.